Taher Abbasi Selected Research

Taher Abbasi Research Topics

Disease

22	Neoplasms (Cancer) 11/2021 - 03/2011
4	Multiple Myeloma 01/2019 - 11/2011
3	Inflammation (Inflammations) 01/2019 - 09/2013
3	Hepatocellular Carcinoma (Hepatoma) 10/2013 - 03/2011
2	Glioblastoma (Glioblastoma Multiforme) 11/2020 - 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 08/2017
1	Glioma (Gliomas) 01/2016
1	Carcinoma (Carcinomatosis) 01/2014
1	Carcinogenesis 01/2014
1	Stomach Neoplasms (Stomach Cancer) 11/2012
1	Prostatic Neoplasms (Prostate Cancer) 07/2011
1	Neoplasm Metastasis (Metastasis) 07/2011

Drug/Important Bio-Agent (IBA)

3	ChemokinesIBA 01/2019 - 10/2013
3	CytokinesIBA 01/2019 - 10/2013
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2016
3	Pharmaceutical PreparationsIBA 06/2016 - 05/2014
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2011 - 03/2011
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2019
2	Biological ProductsIBA 11/2021 - 01/2014
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2014 - 05/2012
2	Protein Kinases (Protein Kinase)IBA 10/2014 - 05/2012
2	Transcription Factors (Transcription Factor)IBA 11/2011 - 07/2011
1	Temozolomide (Temodar)FDA LinkGeneric 11/2020
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	Azacitidine (5 Azacytidine)FDA Link 01/2019
1	LipopolysaccharidesIBA 01/2019
1	LipopeptidesIBA 01/2019
1	B7-H1 AntigenIBA 12/2016
1	withaferin AIBA 01/2016
1	LactonesIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2015
1	caryophyllene oxideIBA 10/2014
1	Volatile Oils (Essential Oils)IBA 10/2014
1	SesquiterpenesIBA 10/2014
1	Antineoplastic Agents (Antineoplastics)IBA 05/2014
1	AlpelisibIBA 04/2014
1	Topoisomerase I InhibitorsIBA 01/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Drug CombinationsIBA 01/2014
1	pyrazolanthroneIBA 01/2014
1	JNK Mitogen-Activated Protein KinasesIBA 01/2014
1	Antimicrobial PeptidesIBA 10/2013
1	Emodin (Archin)IBA 10/2013
1	ElastinIBA 09/2013
1	3-methylquercetinIBA 11/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2012
1	honokiolIBA 05/2012
1	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 05/2012
1	celastrolIBA 11/2011
1	src-Family KinasesIBA 07/2011
1	AndrogensIBA 07/2011
1	Ursolic AcidIBA 07/2011
1	buteinIBA 03/2011

Therapy/Procedure

11	Therapeutics 11/2020 - 05/2012
4	Immunotherapy 11/2021 - 12/2016
2	Precision Medicine 11/2020 - 01/2018
1	Radiotherapy 11/2020